Podcasts about Hartman

The documentary short 'All The Empty Rooms,' follows reporter Steve Hartman and his photographer through their work memorializing the bedrooms of children killed in school shootings across the United States. Hartman discusses those heartbreaking efforts, along with the film's director Joshua Sefteland executive producer Lisa Cortes. 'All The Empty Rooms' is nominated for Best Documentary Short at this year's Academy Awards and is streaming now on Netflix. Image: courtesy of the filmmakers

We'd love to hear from you! Click here to send us a text. In this episode of The New Wave Music Podcast, Steve sits down with Jesse Hartman from LAPTOP for a deep dive into the band's past, present, and future. Jesse takes listeners back to the beginning, sharing the story of how LAPTOP first came together and reflecting on the early days of the band, including the debut album Opening Credits and the follow-up release The Old Me vs The New You. Along the way, he discusses the songwriting process behind those early records and even talks about the band's unique take on a classic track by Billy Joel.The conversation also explores LAPTOP's 2009 album Don't Try This at Home, the band's recent reboot, and the new wave of music that is introducing the project to a new generation of listeners. Jesse shares stories from performing live, reflects on standout moments from the band's catalog, and gives listeners insight into where LAPTOP is headed next. LAPTOP:  https://www.laptoptheband.com/Support the show

Message: Replacement Theology Songs: Easter Medley  Host: Dennis Campbell – President/CEO – MissionGO The post Dr. Fred Hartman – Replacement Theology appeared first on MGO Radio/Canada's National Bible Hour.

Are you silently battling thoughts that won't let you go? In this eye-opening episode, Julieann Hartman explores the biblical call to confess our sins to one another—not for shame, but for healing. The enemy thrives in secrecy, using hidden struggles to torment our minds and keep us bound. Julieann emphasizes the importance of finding safe, trustworthy people to open up to and reminds us that isolation only deepens the pain. Freedom begins when we bring things into the light—because what's exposed loses its power to control us.

Důvody pro zvyšování výdajů na obranu a bezpečnost země rostou. Prohlásil to v Poslanecké sněmovně prezident Petr Pavel. Ta v těchto dnech projednává návrh státního rozpočtu na letošní rok. Výdaje na zajištění bezpečnosti v něm zahrnuté názorně dokazují, že jejich objem stagnuje.

Důvody pro zvyšování výdajů na obranu a bezpečnost země rostou. Prohlásil to v Poslanecké sněmovně prezident Petr Pavel. Ta v těchto dnech projednává návrh státního rozpočtu na letošní rok. Výdaje na zajištění bezpečnosti v něm zahrnuté názorně dokazují, že jejich objem stagnuje.Všechny díly podcastu Názory a argumenty můžete pohodlně poslouchat v mobilní aplikaci mujRozhlas pro Android a iOS nebo na webu mujRozhlas.cz.

In this episode, I'm joined by Dr Aaron Hartman, an integrative and functional medicine physician from Richmond, Virginia, and founder of Richmond Integrative & Functional Medicine. He's also the author of UnCURABLE and host of the Made for Health podcast. Dr Hartman shares the powerful story that changed the trajectory of his career: adopting his daughter Anna, who was exposed to crystal meth in utero, had a stroke before birth, was diagnosed with cerebral palsy, and was told she would never walk, talk, or see. His refusal to accept "hopeless" prognoses led him into deep research, root-cause medicine, and a lifelong commitment to personalised care. What we cover Anna's story and why it matters Being advised to place a feeding tube as "standard care," and what happened when the family declined. How a simple missing detail (using the wrong growth chart) nearly led Anna down a path of unnecessary procedures. Anna's progress today: ongoing skill gains year after year, including major improvements in vision and independence. How Dr Hartman became an integrative and functional medicine doctor Why "incurable" is often a reflection of system blind spots, not a true end point. His deep dives into functional medicine, functional neurology, peptides, and "lipid medicine," and how continuous learning shaped his approach. Why many chronic illnesses get missed Common overlooked root causes he sees in clinic: mold-related illness, chronic infections (like Lyme), hidden autoimmune issues, hypermobility patterns, nervous system dysregulation, and basic nutrient deficiencies. A practical framework: foundations first Dr Hartman's emphasis on starting with basics such as sleep, stress, gut health, nutrition, and environmental exposures before chasing "advanced" interventions. Mold and environmental illness Removing exposure as step one. Supporting detox pathways with binders and targeted nutrition strategies (always individualised and supervised). Anti-ageing = lowering inflammation The concept of "inflammaging" and why food quality, sleep, and stress regulation are the real foundations of longevity. What he would change about modern healthcare Why the system's incentives and regulations often prevent clinicians from practising deep, personalised medicine. About Dr Aaron Hartman Dr Hartman opened Richmond Integrative & Functional Medicine to provide advanced integrative and functional medicine evaluation and treatment, including complex chronic illness care. His book UnCURABLE shares his family's story and offers a roadmap for patients who have been told "nothing can be done." Resources and links Main hub (clinic, media, podcast): **https://aaronhartmanmd.com/** Clinic: Richmond Integrative & Functional Medicine: **https://richmondfunctionalmedicine.com/** Book: UnCURABLE: **https://uncurablebook.com/** Podcast: Made for Health: **https://podcasts.apple.com/us/podcast/made-for-health/id1785446558** Instagram: **https://www.instagram.com/aaronhartmanmd/** Reminder: This podcast is for educational purposes only and is not medical advice. Please speak with your healthcare provider before making changes to your health routine.  

*Content Warning: medical trauma, sexual violence, rape, domestic violence, intimate partner violence, gender-based violence, sexual assault, human trafficking, and abuse. Free + Confidential Resources + Safety Tips: somethingwaswrong.com/resources   Follow Kayla Hartman: Instagram: http://www.instagram.com/thevenakayla Threads: https://www.threads.com/@thevenakayla/ LinkedIn: https://www.linkedin.com/in/kayla-hartman-345a7911a/ SWW Sticker Shop!: https://brokencyclemedia.com/sticker-shop SWW S25 Theme Song & Artwork: The S25 cover art is by the Amazing Sara Stewart instagram.com/okaynotgreat/ The S25 theme song is a cover of Glad Rag's U Think U from their album Wonder Under, performed by the incredible Abayomi instagram.com/Abayomithesinger. The S25 theme song cover was produced by Janice “JP” Pacheco instagram.com/jtooswavy/ at The Grill Studios in Emeryville, CA instagram.com/thegrillstudios/ Follow Something Was Wrong: Website: somethingwaswrong.com  IG: instagram.com/somethingwaswrongpodcast TikTok: tiktok.com/@somethingwaswrongpodcast  Follow Tiffany Reese: Website: tiffanyreese.me  IG: instagram.com/lookieboo *Sources: -“IAFN - International Association of Forensic Nurses.” International Association of Forensic Nurses - Research.Educate.Lead, 16 Aug. 2023, www.forensicnurses.org/page/IAFN/-“Sexual Offense Evidence Collection Kits, Rape Kits, Consent Form.” NYS Division of Criminal Justice Services, www.criminaljustice.ny.gov/evidencekit.htm

Have you ever been told your labs are “normal” — but you don't feel normal?In this episode, I sit down with integrative and functional medicine physician Aaron Hartman, author of Uncurable, to unpack the dangerous gap between normal and optimal — especially for women in midlife.We cover:What lab reference ranges really meanThe cardiovascular markers every woman should know (hs-CRP, LDL particle number, Lp(a), ApoB, homocysteine)Why LDL alone is outdated thinkingThyroid testing beyond TSH (free T3, free T4, reverse T3, antibodies)Ferritin, B12, iodine & nutrient blind spotsEstrogen, progesterone & testosterone — when to start and what actually protects your brain and heartStatins, diabetes risk, and mitochondrial healthGut health, inflammation & autoimmune triggersWhy lifestyle is foundational — and where advanced longevity tools fit inDr. Hartman explains how heart disease begins decades before symptoms appear, why hormone replacement therapy dramatically reduces risk when used appropriately, and how women can advocate for themselves in a system that often dismisses midlife symptoms.If you care about your brain, your bones, your heart — and living strong into your 80s and 90s — this conversation is essential.Did you miss something? Check out the transcripts of the episode!You can find Aaron Hartman, MD at https://richmondfunctionalmedicine.com/Instagram https://www.instagram.com/aaronhartmanmd/His book, Uncurable: From Hopeless Diagnosis to Defying All Odds, is available where you buy books. _________________________________________If you're doing “all the right things” and still feel stuck, adding a layer of support may be an option. I've partnered with a trusted telehealth platform offering modern solutions for women in midlife—including micro-dosed GLP-1 and other peptide therapies. https://elliemd.com/michelefolan - Create a free account to view all products. Follow us on Instagram https://www.instagram.com/askingforafriend_pod/ ✨ Sign up for my weekly newsletter: https://michelefolanfasterway.myflodesk.com/i6i44jw4fq Like to connect? Email me at askingforafriendpodcast1@gmail.com Transcripts are created with AI and may not be perfectly accurate. Disclaimer: This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional healthcare services. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your qualified healthcare provider with any questions regarding a medical condition.

Dr. Deb Muth 0:00 Welcome back to Let’s Talk Wellness Now. I’m your host, Dr. Zab, and we are continuing our discussion this week on 0:08 peptides. And so, if you haven’t heard our first conversation about peptides, 0:13 please go back and look at that episode. We talk all about the manufacturing, the safety, the quality of peptides, and we 0:20 dove into GLP1s. And today we’re going to dive into peptides for sexual 0:26 wellness, immune function, growth hormone, and all the amazing fun things 0:32 we can do with peptides. So, as usual, grab your cup of coffee or tea, settle 0:37 in, and let’s talk wellness now. And we’re going to take a short pause from our sponsor. I know we’ve got to do 0:44 that, you guys. They’re who keep us on the air. So, I’m going to pause for just a minute and be right back after this 0:50 message from our sponsor. Ladies, it’s time to reignite your vitality. Primal 0:56 Queen supplements are clean, powerful formulas made for women like you who want balance, strength, and energy that 1:03 lasts. Get 25% off at primal queen.com. Serenity Health. That’s primalqueen.com. 1:10 Serenity Health. Because every queen deserves to feel in her prime. All 1:15 right, everybody. We are back. And are you ready? We are talking all things peptide and I am opening the show today 1:23 with sexual wellness. Yes, I’m going there, you guys. I am going there. You 1:29 know, this has really become a big issue for people um of all ages. It’s not just 1:3 4us older people. It’s younger people, too. And there’s a whole variety of reasons why we have sexual dysfunction. 1:42 And when we’re talking about sexual dysfunction, we’re not just talking about it doesn’t work, right? Or I can’t 1:48 reach orgasm. A lot of it is around desire and um the thought of it and 1:54 wanting to connect, wanting to be kinder to one another, wanting to be touching 2:00 one another. A lot of it resolves or revolves around that. And so there are some peptides that can help us and I’m 2:08 really excited to be able to talk about those today. So the first one is called PT-141. 2:14 This targets the brain not the periphery. Right? So for many women I 2:20 will always tell you sex starts between here. It is a brain thing for us. It is 2:26 not necessarily a physical thing. For guys that’s a little different. It’s very physical. For women it’s all in our 2:32 brain. So tip for you men that are listening. You have to prime your woman’s brain first if you want her to 2:38 have sex with you that night. You have to be nice to her. You have to bring her flowers. Do the dishes for her. Do 2:45 something kind. Bring her a cup of coffee or tea or a glass of wine. Take her to dinner. You have to woo her. And 2:51 I don’t care how long you’ve been married. That has to happen. And tip number two, don’t say anything stupid 2:57 that day. I’m just being honest. When you guys say things that make us upset, 3:03 that lingers with us for the rest of the day. And it’s it’s a turnoff for us. And 3:08 for a lot of women, we can’t get past that when it comes time to snuggle at night. And sex doesn’t always have to be 3:14 at night either. So, you can tell I really love talking about this conversation, but we’re going to get into the peptide part of it because this 3:21 is going to help people. So, um, PT-141 is marketed as I’m going to slaughter 3:28 this name, Vali, and it represents a fundamentally different approach to 3:34 sexual dysfunction than the PDE5s inhibitors like Slenden, Viagra, 3:40 Tedataphil, which is Seialis. And while the PDE5 inhibitors work specifically by 3:47 enhancing blood flow to the genital tissues, PT-141 works centrally in the brain by 3:54 modulating neural s neural circuits involved in the sexual desire and 4:00 arousal. Now PT-41 is a cyclic hpatipeptide. It’s seven amino acid 4:07 peptide arranged in a cyclic structure that acts as a melanoortin receptor 4:13 agonist and with particularly the infinity for MC3R and MC4R subtypes. 4:20 It’s actually a metabolite of the melanotan 2, a peptide originally 4:26 developed for tanning that was also found to enhance sexual desire in early 4:31 studies. Now the melanoortin system in the brain is involved in multiple functions including energy homeostasis 4:39 but it also is involved in sexual motivation and arousal behaviors. The FDA approved PT-141 in 2019 specifically 4:48 for the treatment of acquired generalized hypoactive sexual desire 4:54 HSDD in permenopausal women. So for the first time we have a medication that was 5:01 approved by the FDA to use for women for sexual dysfunction. We have had all of 5:07 these seialis tedataphil viagros for men but we had nothing for women. And so 5:12 this is amazing that this is available for women and approved by the FDA. It’s a big deal. This represents the first 5:19 and only FDA approved medication specifically targeting these circuits of sexual desire rather than the peripheral 5:27 arousal mechanisms. And this indication is quite specific, meaning it was developed at some point, not lifelong. 5:35 So I if you’ve had sexual dysfunction your entire life, this medication was 5:40 not approved for you. But if it’s something that you developed over time, like when you went through pmenopause or 5:46 menopause or some women have this experience happen after childirth, that’s what we’re talking about here. 5:53 Now, it’s also not just um supposed to be used if you dislike your partner, 5:59 right? If your relationship is bad and you dislike your partner, this probably isn’t going to fix a ton. It might help 6:05 a little bit, but that’s not what it’s meant for. So, you really have to know what you’re using it for and why. And 6:11 the other thing that I would say is this is something that we don’t go to if your hormones are not balanced properly. You 6:17 have to balance your hormones properly before using something like this because it still may not work. Now, the only 6:24 caveat to that is if you’re a woman that has a risk of breast cancer and can’t use hormones, then that’s a different 6:31 story and we would have that conversation about whether or not this medication would be appropriate for you. Now, the FDA label specifies PTA1 uh 6:39 PT-141 as it not being indicated for HSDD in causes where low sexual desire 6:46 is due to coexisting medical or psychiatric conditions, problems with relationships, like we had talked about, 6:53 side effects to medications or other substance use. This specifically reflects the importance of differential 6:59 diagnosis. Low sexual desire can have many root causes and PT-41 is only 7:05 appropriate when those causes have been ruled out. Now, I have I used PT41 in 7:10 people who have sexual dysfunction issues as a result of using 7:16 anti-depressants. Yes, I have. I’ve used Flynn in that effect as well. And it 7:21 does work sometimes, but it doesn’t work completely. But you need to know that that is not what the approval is for the 7:27 FDA. So that is done in something that we call off label use. So very important 7:33 to know. Now in these clinical trials leading to FDA approval, this was published by Kinsburg and colleagues in 7:40 obstetrics and gyne gynecology in 2019. PT-141 demonstrated statistically 7:46 significant improvements in sexual desire and decreases in distress related 7:51 to low desire compared to placebo. The effects manifest over 45 minutes to 7:56 several hours after the injection and the mechanisms involved modulation of dopamine and melanoorton pathways in the 8:04 hypothalamus and the brain regions that involved sexual motivation. Now cardiovascular effects of PT 141 require 8:12 careful attention. This drug causes transient increases in blood pressure about 3 to four points and transient 8:20 decreases in heart rate. And because of this, it is contraindicated in patients 8:25 with uncontrolled hypertension or known cardiovascular disease. And it has been studied in patients who’ve had recent 8:32 cardiovascular events or sorry hasn’t been studied hasn’t been studied in patients who’ve had recent 8:39 cardiovascular events. So patients need to have their blood pressures checked before starting therapy. Nausea is 8:45 extremely common. It is one of the biggest things I often will tell people to take an anti-nausea medicine if 8:52 they’re going to do this because the last thing you want to do is inject this medication and think it’s going to give 8:57 you this great time with your partner and you’re so nauseated that you can’t even perform, don’t want to kiss, don’t 9:05 want to do anything. It it can be pretty profound for some people. um it does affect about 40% of the patients in 9:12 clinical trials which is why many clinicians require or recommend an 9:17 anti-nausea medication like I had just said other common adverse effects include flushing injection site 9:24 reactions headache in about 13% of the population which I have seen worse if 9:30 people are prone to headaches and the headaches are pretty intense so I will also have them premedicate if they have 9:36 that um sensitivity ity with a Tylenol or Advil, Alie, whatever it is they 9:42 typically use for their headaches to help prevent that from occurring. Now, some patients also experience a 9:50 generalized hyperpigmentation of their skin, particularly in areas with chronic friction, and this may not be reversible 9:57 after discontinuation. So from an integrative perspective, PT-41 10:03 represents one tool in addressing female sexual dysfunction, but it should never be the first or only intervention. And 10:11 low sexual desire in women is complex. Multiffactorial involving hormonal imbalances, low testosterone, estrogen 10:18 deficiency, progesterone imbalances, thyroid dysfunction, adrenal dysfunction, and with elevated or 10:24 disregulated cortisol levels, sleep deprivation, relationship issues, unresolved trauma, including sexual 10:31 trauma, chronic pain, body image concerns, and medication side effects such as SSRIs are notorious for this. So 10:39 a comprehensive hormone panel including total and free testosterones, estradile, 10:45 progesterone, DHEA, thyroid function in cortisol assessment, ideally four-point 10:51 cortisol, salivary should precede any pharmacological intervention. And additionally, addressing the 10:57 psychological component and relationship dimensions through appropriate therapy is necessary. I have a lot of patients 11:03 that say, “This is just too much work for sex. I don’t want the side effects. I don’t want to deal with this.” and that’s totally fine. But for some 11:09 people, their sexual dysfunction is actually causing more problems on their 11:14 relationship and they want to do something to fix that. And just know that if you’re using a peptide like this 11:20 that comes with some of these side effects and you have to premedicate for it, it is not the end of the world. Um, 11:27 but it may be a possibility that you may need that. So, let’s dive into body composition and growth hormone access. 11:34 So Tesmarellin is the only FDA approved GH 11:40 analog. Tesarelin is marketed as Agrifta and Agria SV. It is a synthetic analog 11:48 of human growth hormone releasing hormone. So GH RH human growth hormone 11:53 releasing hormone. These things are such long names it’s confusing and it’s difficult to spit out, right? It 11:59 consists of 44 amino acids. The structure is identical to our own 12:05 body’s growth hormone GHR um with the addition of trans3 hexonol group which 12:14 stabilizes the molecule that extends its half-life compared to the native GHR. 12:19 The mechanism of tesmarellin is elegant in its preservation of physiological 12:24 growth hormone GH secretion patterns and rather than administering an exogenous 12:30 growth hormone directly, tesmarillin binds to the GH receptor in the anterior 12:36 pituitary gland stimulating the indogenous pulsatile release of GH. So 12:42 you know it it’s slower in that stimulation and it pulsates instead of a direct rise and fall. This pusile 12:49 pattern more closely mimics natural GH secretion which occurs in bursts 12:54 primarily during sleep. The GH then stimulates the liver to produce insulin-like growth factor IGF-1 which 13:01 exerts many of the downstream metabolic effects including lipolytic effects on 13:07 the atapost tissue. So fat atapose and how we break that down. The FDA approved 13:13 tesmarellin in 2010 for a very specific narrow indication, the reduction of 13:19 excess abdominal fat in HIV infected patients with lipodistrophe. This 13:25 condition characterized by abnormal fat redistribution with accumulation of visceral body fat and the loss of 13:32 subcutaneous fat in face and limbs developed as a complication of an 13:37 antiviral therapy particularly with older protease inhibitor reg uh 13:42 regimens. The visceral fat accumulation in patients is not just cosmetic. It’s associated with increased cardiovascular 13:49 risk, insulin resistance, and inflammatory markers. The pivotal trial that led to the FDA approval included 13:56 work by Stanley and colleagues published in the annuals of internal medicine in 2014. It demonstrated that tesmarillan 14:03 significantly reduced the visceral atapose measured by CT scan by approximately 15 to 20% which is a 14:10 significant difference to placebo over a short period of time only 26 weeks. Now, 14:16 interestingly, the total body uh weight typically remained stable or even 14:21 increased slightly as the reduction of visceral fat was sometimes offset by increases in lean body mass or 14:28 subcutaneous fat. This highlights an important point. Tesmearellin is not a weight loss drug in its conventional 14:34 sense. Its effects are specifically on body composition and fat redistribution. 14:40 Now the glucose metabolism effects of tesmarellin do require careful monitoring because GH and IGF1 can 14:47 induce insulin resistance. Tesmearellin can increase glucose levels and hemoglobin A1C and in these clinical 14:54 trials glucose tolerance and new onset diabetes occurred in some patients. So 14:59 this creates a therapeutic paradox while res reducing visceral fat we should theoretically improve metabolic health. 15:07 The GH mediated insulin resistance can worsen the glycemic control and patients 15:12 with diabetes require particularly close monitoring. The potential need for adjustment in diabetic medications can 15:19 occur. So I already know what you guys are thinking. Can I use Tesmarellin and 15:24 GLP1 at the same time? And the answer is yes. Especially in those people that we 15:30 know have an insulin resistance already or are prone to that, we can use lowd 15:36 dose micro doing GLP-1 along with tesmarellin to help prevent this from 15:42 occurring um or reduce the risk of it occurring. Now there are some other adverse related problems to growth 15:49 hormone access which include fluid retention which can uh manifest as uh 15:55 ankle swelling, joint pain, muscle pain, paristhesas, carpal tunnel syndrome is 16:01 common to see. Of course you can always see injection site reactions reported about 26 to 30% of the time in the trial 16:08 participants. And this also theoretically has a concern about IGF-1 elevation potentially promoting 16:14 malignancy through long-term data is limited. So we have to be cautious about 16:20 this but it is a growth hormone and anything that is a growth hormone can cause cells to grow and it cannot 16:26 necessarily differentiate between healthy cells and bad cells. So the drug is contraindicated is contraindicated in 16:33 patients with active cancer and in patients with the disruption of the HPA access from conditions like pituitary 16:40 tumors, pituitary surgery, head of radiation um and traumatic brain injury. 16:46 Now off label use of tesmarellin for general anti-aging or body composition 16:51 optimization in non-HIV population, it doesn’t have FDA approval. There is no 16:58 FDA studies. um that promote this, but practitioners do prescribe it for these 17:04 purposes under an experimental and not supported by FDA approved indications. 17:10 And um from an integrative medical standpoint, optimizing natural growth 17:15 hormone secretion through lifestyle interventions, high quality sleep is important. GH primarily is excreted 17:22 during sleep and deep sleep waves. So improving your deep sleep is important. Intermittent fasting can also increase 17:28 growth hormone by five-fold as demonstrated in a Hartman and colleagues uh study from the journal of clinical 17:35 endocrinology and metabolism in 1992. And highintensity interval training, adequate dietary protein, blood sugar 17:42 control, these all can help naturally increase your growth hormone. So, let’s 17:47 dive in now and talk about bone health. peptide hormones um such as oh I’m gonna 17:54 I’m gonna really slaughter this name. Terraparatide is a true bonebuilding 18:01 peptide. It’s marketed as forio. It’s a recumbent form of the first 34 amino 18:08 acids out of 85 of the human parathyroid hormone PTH. It represents a unique 18:13 approach to osteoporosis treatment because it’s one of the few truly anabolic anabolic bone therapies meaning 18:21 it actively binds new bone rather than simply preventing bone loss. The biology 18:26 of parathyroid is fascinating and seemly contraindicated or uh contradictory. 18:32 Continuously sustained elevations of PTH as occurs in hyperarathyroidism 18:37 is catabolic to bone. So people who have hyperarothyroidism typically have significant bone loss 18:44 especially before it’s diagnosed and it causes causes increased bone 18:49 reabsorption loss of bone density increased fracture risk and however 18:55 intermittent exposure to PTH as achieved with once daily uh injections of forio 19:01 has the opposite effect. This intermittent exposure preferentially stimulates osteoblasts bone building 19:08 cells over osteoclasts bone reabsorbing cells and it leads to 19:13 the net bone formation. So terraparatide binds to the PTH receptors on 19:20 osteoblasts and renal tubular cells in bone. It increases the number of 19:25 activity of osteoblasts stimulating the differentiation of osteoblast precursor cells and may 19:32 reduce osteoblast apoptosis basically programmed cell death allowing this bone 19:37 building cell to work longer. The result is increased bone formation, improved bone architecture and tbacular 19:45 connectivity and ultimately increased bone mineral density um particularly in the hip and the spine which is so 19:51 difficult to regain. The FDA approved this medication in 2002 based on pivotal 19:57 studies by Near and colleagues published in the New England Journal of Medicine in 2001 which demonstrated significant 20:05 reductions in vertebral and non-vebral fractures in post-menopausal women with 20:11 osteoporosis. specifically uh reduced new vertebral fractures by 20:17 65% and nonvettebral fragility fractures by 53% 20:23 compared to placebo over a median followup of 21 months. This is really 20:29 incredible because we have not seen this kind of um change uh in other 20:35 medications that we’ve used for osteoporosis. So current FDA approval 20:40 indicates uh this for post-menopausal women with osteoporosis at high risk for 20:46 fracture, men with primary or hypoconatal osteoporosis at high risk for fracture 20:53 and men and women with glucocord cord glucocordide 21:00 induced osteoporosis at high risk for fracture. The high risk qualifier is 21:05 important. uh terrapeptide is reserved for patients with severe osteoporosis, 21:11 multiple fractures, very low low bone density and those who have failed or are 21:16 intolerant of other therapies. The most significant concern for this medication 21:21 is highlighted in a boxed warning with rat toxicology studies where it caused 21:27 osteioaroma which is a bone cancer in a dose dependent and treatment duration dependent manner. The revolence of this 21:34 finding to humans is debated. Rats have fundamentally different bone biology than humans with continuous bone growth 21:41 throughout life and different PTH receptors. Now post marketing 21:46 surveillance in humans hasn’t shown a clear increase in osteocaroma risk but 21:51 theoretically concerns persist and because of this terapeptide is 21:57 contraindicated in patients at risk baseline risk for osteioaroma 22:02 including those with pageantss disease of the bone unexplained elevations of alkaline phosphate prior skeletal 22:10 radiations bone metastases or skeletal malignancies and pediatric patients or young adults 22:16 with open hyes. There’s also a lifetime treatment duration of only 2 years and 22:22 terrapeptide can cause transient hypercalcemia. So an elevated blood calcium and as PTH normally increases 22:31 calcium levels by enhancing bone reabsorption, increasing renal calcium 22:36 reabsorption and promoting activation of vitamin D which increases intestinal calcium absorption. Some patients 22:43 experience orthostatic hypotension within 4 hours of injecting requiring 22:48 caution in at risk populations for blood pressure. Common side effects include 22:53 muscle pain, joint pain, pain in the limbs, nausea, headache, and dizziness. So from an integrative bone health 23:00 perspective, terrapeptides should be part of a comprehensive strategy. Adequate calcium intake, 500 to a,000 23:08 milligrams of calcium a day from food and supplements combined. and vitamin D. 23:13 Getting vitamin D levels of at least 50 to 80 are essential for the drug to work 23:20 optimally. But beyond this, bone health requires vitamin K2, which directs calcium into the bones rather than soft 23:27 tissues, magnesium as a co-actor in bone metabolism, trace minerals like boron, 23:33 copper, silica, and of course, adequate protein intake, which many of us, especially as women, don’t do 0.8 8 to 1 23:42 gram of protein per kilogram of body weight, weightbearing exercise. Of 23:47 course, these all provide mechanical signals that complement the biochemical 23:52 symbol uh signals of terrapeptide. Sequential therapy is also critical. The 23:58 bone mass gains from terraparatide can be lost if patients don’t transition to 24:05 an anti-resorbbitive agent a bisphosphinate after completing this therapy and the anabolic effects to 24:12 build bone but maintaining the new bone requires preventing excess reabsorption. 24:18 So positive things about this but there are definitely some concerns as well. So 24:23 the next one we’re going to talk about is Lu Prolrooide. It is marketed under 24:29 the multiple brand names of Lupron, Depo, Eligard, and it’s a synthetic 24:34 nonapeptide analog of naturally occurring ginonadotropen releasing 24:39 hormone G&R, also called luteinizing hormone releasing hormone, LHR. 24:46 It’s a fascinating example of how manipulating natural hormonal feedback systems can create therapeutic effects. 24:53 So, G&RH is normally secreted in a pulsatile fashion by the hypothalamus 24:59 and travels to the anterior pituitary where it binds to G&R receptors and 25:05 stimulates the release of luteinizing hormone LH and follical stimulating hormone FSH. These ginatotropins signal 25:13 the ovaries or the testes to produce sex hormones, estrogen, progesterone in 25:18 women, testosterone in men. Uh, luoprololi lupron as a GNR agonist 25:26 initially mimics the action of natural G&R causing an acute flare response with 25:33 uh increased LHFSH secretion which temporarily increases sex hormone 25:38 production. However, the continuous administration which is in the depo 25:44 formulations, the GNR receptors in the pituitary become desensitized and 25:50 downregulated. And after about 2 to four weeks of continuous exposure, LH and FSH 25:56 secretion is profoundly suppressed, leading to what’s termed as chemical 26:01 castration. Testosterone levels in men drop to castrated levels less than 50 26:08 and estrogen production is marketkedly suppressed in women. This bifphasic 26:13 response creates both therapeutic applications and management challenges in prostate cancer where tumor growth is 26:20 typically androgen dependent and the ultimate goal is testosterone suppression. However, the initial 26:27 testosterone surge during the flare phase can temporarily worsen symptoms potentially causing increased bone pain, 26:34 urinary obstruction, or even spinal cord compression in patients with metastatic 26:40 disease. This is why uh luoprolide is often started with an anti-ad androgen 26:47 like bicladamide for the first two to four weeks to block the effects of the 26:52 testosterone surge. The FDA has approved lupalide for multiple indications across 26:59 formulations. In oncology, it’s used for palletive treatment of advanced prostate cancers. In gynecology, various 27:06 formulations are approved for endometriosis, for pain management and lesion reduction and for fibroids. 27:13 Typically for pre-operative uh hematological improvement in anemic patients. In pediatrics, it’s used for 27:20 central precocious p puberty basically to halt the premature sexual development of these young people. Now, there are 27:28 adex uh adverse effect profile that reflects profound hormonal suppression. 27:34 In men treated for prostate cancer, hot flashes affect about 59% of the patients. Other common effects include 27:41 general pain, swelling, bone pain. Um long-term use of these medications leads 27:47 to metabolic changes. It increases fat mass. It decreases lean mass. It worsens 27:53 insulin sensitivity, disrupts the cholesterol uh lipid panels, increases 27:59 diabetic risk, has some concerns over cardiovascular disease. And the metaanalysis have shown increased risks 28:06 of heart infarction, myocardial inffection, sudden cardiac death, and stroke in populations receiving 28:13 long-term androgen deprivation therapy. The bone effects are particularly dramatic. Without sex hormones, bone 28:20 density decreases significantly, typically 3 to 4% per year during the 28:26 first two to three years of therapy. And this bone loss may not fully be reversible after the the therapy 28:32 discontinues. The American Society of Clinical Oncology recommends bone density monitoring and consideration of 28:39 bisphosphinates uh in men receiving long-term androgen deprivation. In women treated for 28:46 endometriosis or fibroids, the estrogen suppression creates a hypoestrogenetic state similar 28:54 to menopause. Hot flashes affect 90% of patients with other common effects 29:00 including headaches, emotional irritability, decreased sex drive, vaginal dryness, bone density loss. And 29:08 because of these bone concerns and treatment duration with endometriosis, typically limited to six months, though 29:14 some formulations allow for longer use with adback hormonal therapy to 29:20 partially mitigate these side effects. The mood and cognitive effects can be s 29:25 significant. I’ve seen it over the years. the depression, the memory impairment, difficulty focusing and 29:31 concentrating. It can be very very traumatic and the quality of life that 29:37 happens for these uh women and men can be unbearing for many of them. Um, from 29:44 an integrative perspective, patients receiving this medication need comprehensive support care. Bone health 29:51 interventions using calcium, vitamin D, vitamin K2, weightbearing exercise, 29:58 cardiovascular risk management becomes critical, including blood pressure monitoring, lipid management, diabetes 30:05 screening. For hot flashes management, some patients respond to black coohos, 30:10 sage, or vitamin E. Though evidence is mixed and individual response varies, 30:16 omega-3s may help with the mood and the inflammation, resistance training becomes specifically important to 30:22 preserve lean muscle mass in the face of hormonal suppression. 30:27 Now there’s something called calcetonin salamon which is marketed as miaelin. 30:34 It is a nasal spray. It is now discontinued. And foral is the new 30:39 synthetic polyeptide hormone of 32 amino acids identical to calcetonin of salamon 30:47 origin. It represents an interesting case study in how initial promise gives 30:52 way to safety concerns that regulate a therapy to historical footnote status. 30:58 Calcetonin is naturally occurring hormone in humans. It’s secreted by the paraphalicular sea cells in the thyroid 31:04 gland. Its primary physiological role is to lower blood calcium levels by 31:10 directly inhibiting osteoclast activity, reducing bone reabsorption, increasing 31:16 renal calcium secretion or excretion, and possibly reducing the intestinal 31:21 calcium absorption. So, salamon calcetonin is used therapeutically because it’s more potent and longer 31:27 acting than human calcetonin. The FDA initially approved calceton and salmon 31:34 for several indications post-menopausal osteoporosis in women more than five 31:39 years post-menopausal when alternative treatments are not sustainable. Padet’s 31:44 disease for bone and hypercalcemium as emergency treatments. The nasal spray formulation is particularly popular for 31:53 osteoporosis because it offered a non-injectable alternative to bisphosphinates. 31:58 However, in 2012, the European Medicine’s Agency, EMA, conducted a 32:05 comprehensive safety safety review after a poolled analysis of 21 clinical trials 32:10 involving over 10,000 patients showed a statistically significant increase in 32:15 malignancy risk in patients treated with calceton salamon compared to compared to 32:21 placebo. The overall malignancy rate was 4.1% in calcetonin treated patients 32:28 versus 2.9% in placebo patients. The types of cancer 32:34 varied with no single cancer type predominating, making it difficult to establish a clear mechanistic link. 32:41 However, the signal was concerning enough that the EMA restricted the use of calcetonin containing medicines. In 32:48 the United States, the FDA issued communications about malignancy signal and conducted its own review. While they 32:56 didn’t fully withdraw the drug, the cons consensus shifted dramatically. The nasal spray formulations miaelson was 33:03 voluntarily discontinued by the manufacturer and current clinical practice guidelines now consider 33:10 calcetonin salamon as a second line or lower option for osteoporosis. While 33:15 behind bisphosphinates, dennism mob, uh, terrapeptide, the analesic effect of 33:21 calcetonin in bone pain, particularly in acute vitibbral, uh, compression 33:26 fractions from osteoporosis or pageantss disease may still provide a role for short-term use in these selected 33:32 patients. The mechanism of this pain relief is unclear, but may involve 33:38 effects of endorphin systems and/or direct actions on pathways. The history serves as an important reminder in 33:45 peptide medicine. Initial approval and early clinical use does not guarantee 33:50 long-term safety effects. Post marketing surveillance and poolled analysis of the clinical trial data can reveal adverse 33:58 effects that weren’t apparent in initial studies. It also underscores why newer 34:04 agents with better safety profiles um have largely replaced calcetonin in 34:10 clinical practice. So this is really an important thing. Not one thing stays the same forever. We have to change as we 34:18 identify new and better products as we identify problems and concerns. I will 34:24 always tell my patients if you are uncertain of taking a new drug which we 34:30 all should be wait five years. Within five years we are going to find the 34:36 problems that they didn’t find in the clinical studies. Remember, a lot of these clinical studies are small, small 34:43 groups, short periods of time. It’s expensive to do these trials. So, if you 34:49 wait for five years, in the first two to three years, you will see the problem start to emerge. And what are you going 34:55 to look for? You’re going to look for the the news um commercials from lawyers 35:02 suing a drug. And they will tell you what the problem is. and then you can decide, is this something that I want to 35:09 use or not. Don’t jump on bandwagon and be the first one to do this, especially 35:14 if you’re sensitive. You know, give it time so you can see exactly what’s going on. So, I’m going to end our show on 35:22 this and we are going to pick up on part three of peptide therapy in our next 35:28 segment where we’re going to talk about the investigational peptides and some 35:34 exciting things that are happening with that. So, I want to thank you for joining me today on Let’s Talk Wellness 35:39 Now. It’s always a pleasure having a conversation with you guys and I hope this brings value to you with what we’re 35:45 talking about. If you have ideas for topics that you want me to discuss, 35:51 please message us, you can share your comments on Facebook, you can email us, 35:58 um you can get a hold of us however you would like to share that. I do look at the comments below in the episodes as 36:04 well. So you can place your comments there. And once again, one of the best things you can do for me is like, 36:11 subscribe, and share so that we can spread the messages of what we’re doing. 36:16 I do this at no cost. I don’t make any money out of this. I do this as an 36:21 educational purpose for everybody else. I love doing it, but it really helps us 36:28 on the algorithms if you would be just willing to like, subscribe, and share. 36:33 So, thank you for spending your time with me. I know time is important.The post Episode 257 – Peptides for Sexual Wellness & Hormonal Health: PT-141, Growth Hormones, Bone Health & More! first appeared on Let's Talk Wellness Now.

Jezus jest Zbawicielem tam, gdzie najpierw jest Panem. Objawienie o zbawieniu z łaski prowadzi nas do życia pod panowaniem Jezusa.    W trakcie kazania (42:15) został odtworzony utwór: Stromae - Papaoutai (Afro Soul Version), podczas którego wyświetlono polskie tłumaczenie tekstu: Powiedz mi, skąd on pochodzi, Wreszcie będę wiedział, dokąd zmierzam.  Mama mówi, że jeśli dobrze poszukasz,  Zawsze go znajdziesz.  Mówi, że nigdy nie jest daleko,  Że często wyjeżdza do pracy.  Mama mówi, że „praca jest dobra”  Lepsza niż przebywanie w złym towarzystwie, Czyż nie? Gdzie jest Twój Tato?  Powiedz mi, gdzie jest Twój Tato?  Nawet jeśli z nim nie rozmawiasz,  On wie, co jest nie tak.  Och, ukochany Tato, Powiedz mi, gdzie się ukrywasz?  Już chyba tysiąc razy Liczyłem na palcach przy zabawie w chowanego.  [Refren] Gdzie jesteś, Tato? x8  Gdzie jesteś Czy wierzymy w to, czy nie,  Nadejdzie dzień, kiedy nie będziemy już tylko wierzyć.  Dzień, kiedy wszyscy zostaniemy ojcami,  I z dnia na dzień znikniemy.  Czy będą nas nienawidzić?  Czy będziemy godni podziwu?  Przekażemy tylko geny czy geniusz życia?  Powiedz nam, kto rodzi nieodpowiedzialnych?  Och, powiedz nam, kto, no cóż.  Wszyscy wiedzą, jak powstają dzieci, Ale nikt nie wie, jak powstają ojcowie.  Jeśli to wiesz, to pewnie dostałeś to w genach,  Albo tylko udajesz, że wiesz.  Powiedz nam, gdzie są ojcowie?!  Bo już chyba tysiąc razy,  Obgryzaliśmy palce z nerwów, hej!  Gdzie jesteś, Tato? x 8  Gdzie jesteś Gdzie jest Twój Tato? Powiedz mi, gdzie jest Twój Tato?  Nawet gdy z nim nie rozmawiasz, On wie, co jest nie tak.  Och, nieuchwytny Tato, Powiedz mi, gdzie się ukrywasz?  Chyba już tysiąc razy, Liczyłem na palcach przy zabawie w chowanego.  Gdzie jest Twój Tato? Powiedz mi, gdzie jest Twój Tato?  Nawet bez potrzeby rozmowy z Nim, On wie, co jest nie tak.  Och, nieuchwytny Tato, Powiedz mi, gdzie się ukrywasz?  Chyba już tysiąc razy Liczyłem na palcach przy zabawie w chowanego  Gdzie jesteś, Tato? x8  Gdzie jesteś? Alleluja Zapraszamy: www.SpolecznoscMIASTO.plObserwuj nas na:

CBS News Correspondent Steve Hartman joins host Reshma Gopaldas to talk about his Oscar-nominated documentary, All the Empty Rooms, which brings the viewer into the bedrooms of children who were killed in school shootings. Hartman reveals why he chose to do this film, what interview broke him, what brought tears of joy, and why he has hope that the film could change things, so parents and families in America don't have to keep losing children to gun violence. All the Empty Rooms is directed by Joshua Seftel and is streaming on Netflix.Follow on Reshma Gopaldas on YouTube for video episodes.Son of a Binge production credits:Hosted by: Reshma Gopaldas (TW: @reshingbull, IG @reshmago)Artwork by: Laura Valencia (IG @iamlauravalencia)Music by: Kevin Calaba (IG @airlandsmusic)Send us a text, let us know what shows and guests you want us to cover.

Send a text

This episode is a throwback to our time with the owner of Momentvs, Travis Hartman. Leading a company through setting-closing, virtual sales, and valuable partnerships with players in the industry, he knows how to turn zeroes into absolute heroes.CLICK HERE: https://apply.solarpreneurs.com/ https://spotifytop10.solarpreneurs.com/ https://zendirect.com/ https://crmx.app/ https://zapier.com/ https://www.solarscout.app/taylor https://www.youtube.com/@solarpreneurs goals.solarpreneurs.com oneliners.solarpreneurs.com https://solciety.co/ - JOIN SOLCIETY NOW! SIRO APP - LEARN MORE

The SD SportScene Legends Podcast, Season 1, Episode 11. Guest is former Yankton, and Northern State basketball standout Lori (Burckhardt) Hartman.

Have you ever left a doctor's appointment with a prescription but still felt like something was missed? If you have Hashimoto's, you are not alone. In this episode, Dr. Aaron Hartman, a triple board-certified physician, breaks down why bad medical advice and Hashimoto's are more connected than most patients realize, and exactly what you can do about it. You will learn: Why medical error affects autoimmune patients more than you think The four root causes behind every autoimmune disease What kind of provider to look for when you feel stuck Hit play to get started.   Episode 129 about LDN with Pharmacist Steve Anderson   Dr. Hartman's book "UnCURABLE - From Hopeless Diagnosis to Defying All Odds"   JOIN THE HEALTH WITH HASHIMOTO'S COMMUNITY Unlock your wellness journey with the free Health with Hashimoto's community! Join a supportive community that's here for you every step of the way. The Health with Hashimoto's community is on Skool: https://www.skool.com/health-with-hashimotos/about   Find all links on my resource page: https://healthwithhashimotos.com/resources/   ABOUT THE PODCAST & ESTHER: The Health with Hashimoto's podcast will help you explore the root causes of your autoimmune condition and discover holistic solutions to address your Hashimoto's thyroiditis. It is hosted by Esther Yunkin, a registered nurse, holistic health educator, and Hashimoto's warrior.   This podcast is for informational and educational purposes. Please discuss any questions or concerns with your healthcare professional. These statements have not been evaluated by the Food and Drug Administration. Products mentioned are not intended to diagnose, treat, cure or prevent any disease.

Are you battling thoughts of doubt, fear, or discouragement—especially when it comes to your healing? Julieann reveals how these voices are often lies planted by the enemy to make you give up or believe that healing isn't yours. But you have authority in Christ! Learn how to recognize these toxic thoughts, take them captive, and refocus your mind on Jesus—the one who already secured your healing. Be encouraged to stand strong and silence every voice that doesn't align with God's truth.

Služební poměr náčelníka generálního štábu Karla Řehky skončí posledního srpna letošního roku. Současné vedení ministerstva obrany neprojevuje veřejně zájem na jeho prodloužení, proto z armády velmi pravděpodobně odejde. Ostatně sám Řehka na velitelském shromáždění připustil, že na něm vystupuje naposledy.

Služební poměr náčelníka generálního štábu Karla Řehky skončí posledního srpna letošního roku. Současné vedení ministerstva obrany neprojevuje veřejně zájem na jeho prodloužení, proto z armády velmi pravděpodobně odejde. Ostatně sám Řehka na velitelském shromáždění připustil, že na něm vystupuje naposledy.Všechny díly podcastu Názory a argumenty můžete pohodlně poslouchat v mobilní aplikaci mujRozhlas pro Android a iOS nebo na webu mujRozhlas.cz.

What if chronic illness isn't permanent—and your body is far more adaptable than you've been told?   In this powerful episode of Lisa Fischer Said, Lisa sits down with Dr. Aaron Hartman to unpack how epigenetics, nutrition, and personalized medicine are rewriting what we believe about "incurable" diagnoses. Drawing from his daughter's extraordinary healing journey and decades of clinical experience, Dr. Hartman explains why genetics load the gun—but environment pulls the trigger.   You'll learn why conventional medicine often overlooks root causes, how inflammation, trauma, and toxin exposure shape long-term health, and why one-size-fits-all treatments fail so many patients. From gut health and glutathione to GLP-1 medications and muscle loss, this conversation bridges functional medicine and real-world clinical wisdom—without dogma.     If you've ever been told "this runs in your family," struggled with chronic symptoms, or felt dismissed by the healthcare system, this episode offers clarity, empowerment, and science-backed hope.    

This week on the show Maine and Miranda preview the 2026 IBJJF No-Gi GP we break down all of the big black belt, super fights, and every single athlete in the Grand Prix. In the preview section of the show, we discussed every single first round matchup in the IBJJF absolute No-Gi GP. We kick it off discussing the quarterfinal matchups that kickoff the event with the top seed Victor Hugo vs Marlon Tajik, we discussed the recent performances that we've seen from both athletes and how Marlons most recent ADCC European trials performance and brand new black belt will affect him going into this matchup against potential number one seed Victor Hugo.On the same side of the bracket we discussed Javier Barter vs Nick Hartman, with Hartman, coming off of an impressive ADCC trials performance of his own we talk about his guard work and how it may play a factor versus the Panamanian in Barter.In Pedro Marinho vs Diego Pato we discussed the stylistic matchup with Diego being by far the smallest competitor in the entire tournament. We discuss how Pedro will most likely play the Ranger game and leverage his wrestling and guillotine game versus the quick speed and leg locks of Pato. In the final quarterfinals matchup we discussed Michael Pixley vs Gustavo Batista, we talked about the guard work from Gustavo and how it may potentially play an issue with Pixley's passing game we also discussed some potential strategic avenues for Pixley and Gustavo to potentially leverage the IBJJF points in order to come out on top.We also preview the second round and potential finals matchups on each side of the bracket, discussing Victor Hugo's potential pathway to victory as the number one seed in the event. We preview the black belt, super fights on the card as well.With Cole Abate vs Will Wilson a rematch from an earlier event with both coming off of very strong performances at the Europeans will taking the lightweight division and Cole taking silver against Kennedy in the division below.We discussed Helena Crevar vs Aghata Rabelo another rematch that took place in the Gi at the colored belts we discuss Helena's argument for the slot as the number one No-Gi woman in the world.We briefly discuss Sarah Galvão vs Maria Vicentini, and how the recent Atos situation may play into the preparation that Sarah is able to do in the lead up to this match. We also discuss Leo Souza vs Mateo Cardona and Ashlee Funegra vs Yasmyn Castro.In the outro of the show, we discuss recent travel and the upcoming promotion for Corey of the Grappling Rewind later that night.  Recorded 2-23-2026

Jason discusses his transition from a nomadic lifestyle back to homeownership, reflecting on how capitalism efficiently provides global resources. His conversation with Michael Zuber shifts to the impact of artificial intelligence, which Hartman views as a long-term wealth creator despite its potential to cause short-term job displacement and widen the wealth gap. He predicts that while high-tech hubs like Silicon Valley may face local real estate risks due to AI-driven layoffs, the broader housing market remains a strong investment. Jason highlights a significant supply-demand imbalance, noting that the U.S. population has grown by millions since the 2008 recession while housing inventory has plummeted. Ultimately, Jason and Michael suggest that investors can find major opportunities by providing rental housing to a growing population in an increasingly digital economy. https://empoweredinvestorlive.com/ https://onerentalatatime.com/ #AIWealthCreator #JobDisruption #MoonbaseX #HousingInventory #WealthGap #CapitalismEfficiency #RealEstateInvesting #MinimalistNomad #TechMarketRisk #EmpoweredInvestor Key Takeaways: 0:00 The richest homeless man in the world 6:27 Artificial Intelligence and the wealth gap 14:57 Real estate and the short term pains vs. the long term gains 17:58 Chart: US population vs. Inventory and the Great Opportunity     Follow Jason on TWITTER, INSTAGRAM & LINKEDIN Twitter.com/JasonHartmanROI Instagram.com/jasonhartman1/ Linkedin.com/in/jasonhartmaninvestor/ Call our Investment Counselors at: 1-800-HARTMAN (US) or visit: https://www.jasonhartman.com/ Free Class:  Easily get up to $250,000 in funding for real estate, business or anything else: http://JasonHartman.com/Fund CYA Protect Your Assets, Save Taxes & Estate Planning: http://JasonHartman.com/Protect Get wholesale real estate deals for investment or build a great business – Free Course: https://www.jasonhartman.com/deals Special Offer from Ron LeGrand: https://JasonHartman.com/Ron Free Mini-Book on Pandemic Investing: https://www.PandemicInvesting.com

Rebecca Starr is the Vice President of Educational Operations and Regional Strategy for the Shalom Hartman Institute of North America, where she leads the design and implementation process for educational initiatives and guides the regional hubs across the US and Canada. She lives in Southfield, Michigan and works closely with local partners and institutions throughout southeast Michigan. Rebecca is a respected educator and community organizer. She served as an assistant director at Federation's Alliance for Jewish education at the Jewish Federation of Metro Detroit, where she planned and taught professional development classes for teachers in congregational and day schools. She directed and was an instructor at the award-winning Detroit branch of the Florence Melton Adult Mini-School. Rebecca also worked for the National Ramah Commission and Camp Ramah in Canada and expanded educational and outreach initiatives. Raised on a sheep farm in Michigan's Upper Peninsula, Rebecca is a proud product of the University of Michigan where she earned undergraduate degrees in education and Judaic studies as well as a master's degree in social work and a certificate in Jewish communal service. She is married to Rabbi Aaron Starr, a graduate of Hartman's Rabbinic Leadership Initiative (RLI), and they are the proud parents of two sons.   Connect with Jon Dwoskin: Twitter: @jdwoskin Facebook: https://www.facebook.com/jonathan.dwoskin Instagram: https://www.instagram.com/thejondwoskinexperience/ Website: https://jondwoskin.com/LinkedIn: https://www.linkedin.com/in/jondwoskin/ Email: jon@jondwoskin.com Get Jon's Book: The Think Big Movement: Grow your business big. Very Big!   Connect with Rebecca Starr: Website: https://www.hartman.org.il/ Facebook: https://www.facebook.com/ShalomHartmanInstitute X: https://twitter.com/Hartman_Inst Instagram: https://www.instagram.com/shalomhartmaninstitute YouTube: https://www.youtube.com/user/HartmanInstitute Podcasts: https://www.hartman.org.il/program/identity-crisis-podcast/ – Identity Crisis Podcast https://www.hartman.org.il/program/for-heavens-sake-podcast/ – For Heaven's Sake Podcast                                                                                   *E – explicit language may be used in this podcast.

Insurance leaders Brandon Schuh and Nick Hartmann unpack the real impact of AI on insurance operations after Insurify's ChatGPT app triggered a 3.9% drop in the S&P 500 Insurance Index. They separate hype from reality, examining how AI actually enhances productivity versus serving as a scapegoat for strategic workforce reductions. The conversation explores Munich Re's Ergo unit cutting 1,000 positions partly through AI integration, while contrasting this with AIG's ambitious 500,000-submission target using their AIG Assist platform by 2030.Major consolidation continues reshaping the industry landscape with Zurich's £8 billion ($11 billion) acquisition of specialty insurer Beazley following rejected initial bids, and Sompo Holdings' regulatory-approved $3.5 billion purchase of Aspen Insurance. Brandon and Nick also analyze the explosive Brown & Brown versus Howden lawsuit after approximately 200 employees departed during holiday season 2025, revealing tensions around non-compete enforcement and talent mobility in brokerage.Beyond M&A drama, Schuh and Hartman discuss underwriting culture at Lloyd's marketplace where reputation risk follows individual decisions, the legal profession's AI adaptation challenges for entry-level associates, and why operational visibility, not more tools, solves agency productivity problems. They emphasize that AI's greatest value lies in eliminating tedious data analysis so professionals can focus on client relationships and strategic advisory work.Key Takeaways- Insurify's ChatGPT integration caused temporary market panic but represents comparison shopping evolution, not industry disruption- AI productivity gains enable faster policy reviews while freeing teams for high-value client advisory work- Munich Re's Ergo unit (not entire company) plans 1,000 position reductions over five years with AI assistance- Zurich secured Beazley acquisition after multiple rejected bids reached £8 billion valuation- Sompo Holdings (not Sampo) received regulatory approval for $3.5 billion Aspen Insurance acquisition- Howden faces multiple lawsuits after approximately 200 Brown & Brown employees departed simultaneously in December 2025- Lloyd's underwriters carry personal reputation risk with each binding decision in the marketplace- Operational visibility tools like FreeFlow.ai solve agency bottlenecks without replacing producersChapters00:00 Episode introduction and sponsor FreeFlow.ai01:35 Return from hiatus and personal updates06:15 Bourbon tasting and Bob Dylan discussion07:14 Insurify ChatGPT app market impact analysis08:42 AI fears versus realistic productivity gains10:33 Legal profession AI adaptation challenges12:48 Policy review efficiency transformation potential13:07 Munich Re Ergo workforce reduction reality check18:15 Industry consolidation: Zurich/Beazley and Sompo/Aspen deals19:39 Brown & Brown versus Howden employee poaching lawsuit21:38 Underwriting culture and reputation risk at Lloyd's marketplace27:22 Ping An and global insurance employment statistics28:44 AIG Assist platform exceeding submission targets30:50 Two truths and a lie game segment33:42 Closing remarks and next episode previewFact Checks Correction: Sompo Holdings (Japanese insurer), not "Sampo," acquired Aspen Insurance for $3.5 billion with regulatory approval expected H1 2026 Clarification: Munich Re's Ergo primary insurance unit (not entire Munich Re) plans 1,000 position reductions in Germany over five years with AI integration Connect with RiskCellar:Website: https://www.riskcellar.com/Brandon Schuh:Facebook: https://www.facebook.com/profile.php?id=61552710523314LinkedIn: https://www.linkedin.com/in/brandon-stephen-schuh/Instagram: https://www.instagram.com/schuhpapa/Nick Hartmann:LinkedIn: https://www.linkedin.com/in/nickjhartmann/

Send a text

Jason Hartman and Michael Zuber reflect on the success of a recent investment conference and the enduring value of in-person networking. Hartman emphasizes that successful investing requires emotional discipline, noting that many people lose wealth by selling assets at the wrong time due to personal crises or market fear. He uses an iceberg metaphor to explain that while many focus only on cash flow, the most significant financial benefits of real estate often remain hidden "below the water line" in the form of tax advantages and inflation-induced debt destruction. The pair also critiques "crash bros" who incorrectly predicted a housing market collapse, arguing instead that a persistent housing shortage continues to support property values. To conclude, Hartman invites listeners to his upcoming Empowered Investor Live event in California, which will feature prominent financial speakers and data-driven insights. This dialogue reinforces their shared philosophy that income property remains the most historically proven and tax-favored asset class available to investors. #RealEstateInvesting #IncomeProperty #OneRentalAtATime #EmpoweredInvestorLive #JasonHartman #MichaelZuber #FinancialFreedom #TaxBenefits #1031Exchange #HousingMarket #InflationInducedDebtDestruction #WealthBuilding #InvestmentPsychology #PassiveIncome #RealEstateCycles #ChartDaddy #HousingShortage #LongTermInvesting #CashFlow #RealEstateEvents   Key Takeaways: 0:00 Jason's "Trophy" from Michael Zuber's ORAAT event  3:49 The Behavior Gap 7:54 The ICEBERG and the "Dead" investor 11:33 Join us at the https://EmpoweredInvestorLive.com/ conference 15:09 The overall theme   Follow Jason on TWITTER, INSTAGRAM & LINKEDIN Twitter.com/JasonHartmanROI Instagram.com/jasonhartman1/ Linkedin.com/in/jasonhartmaninvestor/ Call our Investment Counselors at: 1-800-HARTMAN (US) or visit: https://www.jasonhartman.com/ Free Class:  Easily get up to $250,000 in funding for real estate, business or anything else: http://JasonHartman.com/Fund CYA Protect Your Assets, Save Taxes & Estate Planning: http://JasonHartman.com/Protect Get wholesale real estate deals for investment or build a great business – Free Course: https://www.jasonhartman.com/deals Special Offer from Ron LeGrand: https://JasonHartman.com/Ron Free Mini-Book on Pandemic Investing: https://www.PandemicInvesting.com

Hey everybody! Episode 185 of the show is out. In this episode, I spoke with Dr. Aaron Hartman MD. Dr. Hartman has a really grounded and holistic approach to health and I really enjoyed our conversation. We spoke about his background, medical school, his his interest in functional medicine, the journey that he embarked on helping to heal his daughter, diagnosis, chronic disease, environmental toxins, diet, the role of spirit in health, and a lot of other topics. I trust you will gain a lot from Dr. Hartman's experience and wisdom. As always, to support this podcast, get early access to shows, bonus material, and Q&As, check out my Patreon page below. Enjoy!This episode is sponsored by Real Mushrooms (https://realmushrooms.com) As listeners, enjoy a discount of 25% off your first order at checkout using the Discount code: UNIVERSETo learn more about or contact Dr. Hartman, visit his website at: https://aaronhartmanmd.comTo learn more about our work, visit our website: https://NicotianaRustica.org To view the recent documentary, Sacred Tobacco, about my work, visit: https://youtu.be/KB0JEQALI_wI will be guiding our next plant medicine dietas with my colleague Merav Artzi (who I interviewed in episode 28) in:February 2026: Sacred Valley of PeruJune 2026: Remote Online DietaJuly 2026: Westport, IrelandNovember 2026: Sacred Valley of PeruIf you would like more information about joining us and the work I do or about future retreats, visit my site at: https://NicotianaRustica.orgIntegration/Consultation call: https://jasongrechanik.setmore.comPatreon: https://patreon.com/UniverseWithinYouTube join & perks: https://bit.ly/YTPerksPayPal donation: https://paypal.me/jasongrechanikWebsite: https://jasongrechanik.comInstagram: https://instagram.com/JasonGrechanikFacebook: https://facebook.com/UniverseWithinPodcastMusic: Nuno Moreno: https://m.soundcloud.com/groove_a_zen_sound & Stefan Kasapovski's Santero Project: https://spoti.fi/3y5Rd4H

This poignant and thought provoking episode is about a battle waged on two fronts. One on the frigid and treacherous waters of the Arctic Ocean and the other on the front page of America's early 20th century print media. This week Nora and Craig welcome renowned author and native Mainer, Darrell Hartman, who's incredibly well researched book, Battle of Ink and Ice: A Sensational Story of News Barons, North Pole Explorers And The Making of The Modern Media, will have you dialing up your thermostat and checking your sources with it's vivid depiction of the daring adventures of explorers like Robert Peary and Frederick Cook and the newspapers that backed their exploits. Listen in as Darrell answers readers questions and shares the lengths he went to while researching this fascinating and shockingly relevant time in world history. It is an episode that is sure to answer questions you didn't know you had about the race for the North Pole and provide valuable perspective to our current media landscape. Visit our Website : ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.fredtheafghan.com/stubbornlypositive⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Join Our Patreon Pack for Video Episodes and so much more: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.patreon.com/StubbornlyPositive⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Follow us on Instagram! @StubbornlyPositive

On America at Night with McGraw Milhaven, Lawrence Yun, Chief Economist at the National Association of REALTORS®, broke down the latest developments in the U.S. housing market, including affordability challenges, mortgage rates, and what buyers and sellers can expect in the months ahead. Next, Dr. Adam Omary of the Cato Institute examined the controversial question of whether an “autism epidemic” truly exists, discussing diagnostic trends, public perception, and how policy and data shape the debate. The show closed with author Jan Hartman, who discussed her book “Lincoln's Speechwriter: John Hay and the Friendship That Inspired American Eloquence,” highlighting the influential partnership behind some of Abraham Lincoln's most enduring words and its impact on American political rhetoric. Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this powerful and deeply personal episode, Rachel sits down with functional medicine physician and adoptive father Dr. Aaron Hartman to explore how early trauma, environmental factors, and holistic healthcare can shape the lives of foster and adopted children.Dr. Hartman shares the story of adopting his daughters through foster care and how his journey parenting a child with complex medical needs transformed his medical practice. Together, Rachel and Dr. Hartman discuss navigating the healthcare system, advocating for special-needs children, and practical ways families can support neurodivergent kids—emotionally, nutritionally, and medically.This conversation offers hope, validation, and actionable guidance for foster, adoptive, and kinship parents navigating complex challenges.

Většina poslanců mandátového a imunitního výboru nedůvěřuje práci orgánů činných v trestním řízení a také justici. Proto nedoporučila Poslanecké sněmovně, aby souhlasila s vydáním Andreje Babiše (ANO) a Tomia Okamury (SPD) k trestnímu stíhání.

Většina poslanců mandátového a imunitního výboru nedůvěřuje práci orgánů činných v trestním řízení a také justici. Proto nedoporučila Poslanecké sněmovně, aby souhlasila s vydáním Andreje Babiše (ANO) a Tomia Okamury (SPD) k trestnímu stíhání. Všechny díly podcastu Názory a argumenty můžete pohodlně poslouchat v mobilní aplikaci mujRozhlas pro Android a iOS nebo na webu mujRozhlas.cz.

When our bodies feel drained, weary, or overcome by symptoms, it can be easy to believe we are powerless—but that is not the truth. Julieann reminds us that our true strength comes from the Lord, not our physical condition. Through scripture and personal testimony, she encourages you to rise up in the authority you've been given in Christ. No matter how weak you may feel, the Spirit within you is mighty. This episode is a call to shift your focus from symptoms to the Savior, and to pull on the supernatural strength and healing Jesus already purchased for you. Tune in and be reminded that you are not alone, not helpless, and certainly not defeated. Miracles happen when we stand firm in God's promises and authority.

Twenty years ago, seven people diagnosed with metastatic HER2-positive breast cancer received a cancer vaccine as part of a clinical trial. Today, they're all still alive. This prompted Zachary Hartman to study the immune systems of the people in the trial to see what was happening. He found that the women had immune cells that continue to recognize the cancer and keep it under control. Now his goal is to make that vaccine even more effective and make it work on other types of breast cancer. Listen to the episode to hear Dr. Hartman explain: how the original study was done how he's working to make the vaccine even more effective how the vaccine might be modified to work on hormone receptor-positive and triple-negative breast cancer

In Parashat Terumah, the Israelites are commanded to build the Mishkan (Tabernacle). Why construct something so exquisite and detailed in the middle of a desert? And what can building something so valuable, then and now, teach us about living through uncertainty? In this episode of TEXTing IRL, Elana Stein Hain and Hartman research fellow Tamara Mann Tweel turn to the rabbinic tradition to explore how building can ground us, offering practices that shape who we become. Episode Source Sheet Watch the video version of this episode ⁠here⁠. You can now sponsor an episode of TEXTing. Click HERE to learn more.  JOIN OUR EMAIL LIST FOR MORE HARTMAN IDEAS

Mortgage rates tripled. The crash never came. In this Episode Kerry Lutz and Jason Hartman break down why U.S. housing didn't collapse when borrowing costs exploded. Nearly 25% of homeowners hold mortgages at or below 3%. About 65% are at 4% or less. That "lock-in effect" crushed supply and froze mobility. Fewer than 800,000 homes are listed nationwide — under 0.6% of America's 140 million housing units. Owners won't give up cheap debt. Inventory stays tight. Hartman believes this imbalance could persist into 2032–2033. Scarcity and utility continue driving prices — even after the rate shock. The conversation then shifts to immigration and rental housing. Hartman argues most undocumented migrants occupy lower-tier rentals, meaning enforcement shifts would likely hit C-class properties first. They also discuss Sun Belt migration trends and investor tools like PropertyTracker and Empowered Investor for sourcing income-producing properties. If you've been waiting for a housing crash, Kerry and Jason explain why it hasn't happened — and what could finally change the equation. Find Jason here: https://www.jasonhartman.com Find Kerry here :https://khlfsn.substack.com and here: https://inflation.cafe    Kerry's New Book "The Armstrong Economic Code: The 5 Truths Investors Must Never Forget" is out now on Amazon!  Get your copy here:   https://a.co/d/bvYbZOz  "The World According to Martin Armstrong – Conversations with the Master Forecaster" is a #1 Best Seller on Amazon. . Get your copy here: https://amzn.to/4kuC5p5

Zdaleka ne všechno, co navrhují, je použitelné. Je třeba brát v potaz také to, co mohou lidé v obtížné sociální situaci unést. Zhruba tímto způsobem hodnotil v listopadu 2022 návrhy Národní ekonomické rady vlády tehdejší premiér Petr Fiala (ODS).

What happens when Emma Lazarus’s “The New Colossus” is no longer read as a civic creed, but as a provocation about who belongs—and what a democracy owes the vulnerable? In this episode, Yehuda Kurtzer reflects on what he perceives as the normalization of cruelty toward immigrants in America, the present state violence being carried out in Minneapolis, and the uneasy silence of Jewish institutions when civil rights are clearly under assault. He then turns his lens toward Israel—asking what it means for Jews in both democracies to draw the line not between “us” and “them,” but between cruelty and compassion. Learn more here and join our mailing list for more Hartman ideas. Subscribe to Identity/Crisis on Apple Podcasts, Spotify or wherever you receive your podcasts.See omnystudio.com/listener for privacy information.

In this episode, Dr. Robert Hartman and Dr. Taylor Cyr join me to discuss a recent paper they wrote. The Paper: https://link.springer.com/article/10.1007/s10670-025-01045-0 Dr. Hartman's Website: https://www.robertjhartman.com/ Dr. Cyr's Website: https://taylorwcyr.com/  Twitter: https://twitter.com/AApologetics Facebook: https://www.facebook.com/adherentapol... Instagram: https://www.instagram.com/adherentapo... TikTok: https://www.tiktok.com/@adherentapologetics

What do you do when symptoms are screaming louder than God's promises? In this honest and empowering episode, Julieann Hartman shares how to stay focused on God's Word—even when pain demands your attention. Learn how to silence the noise and anchor yourself in the truth of His healing power.

On this episode of Reading With Your Kids, host Jed Doherty welcomes Dr. Lauren Hartman, adolescent medicine physician and author of Freeing Children and Young Adults from Shame, Scales, and Stigma. Dr. Hartman dives deep into how diet culture, weight stigma, and even well‑meaning doctors can unintentionally harm kids and teens. She explains how a simple directive like "you need to lose weight" can trigger restrictive eating, eating disorders, and lifelong shame—especially in vulnerable young people. Dr. Hartman offers practical scripts parents can use with doctors, family members, and their own kids to create weight‑inclusive, shame‑free conversations. She talks about setting boundaries with relatives ("in our home, we don't talk about bodies or calories") and focusing on joyful movement, variety in foods, and true health—defined not by size, but by energy, rest, connection, and joy. The conversation also tackles the explosion of GLP‑1 medications like Ozempic, especially in children and teens. Dr. Hartman raises concerns about aggressive marketing, lack of long‑term data, and the message these drugs send about body size diversity. She stresses media literacy, helping kids question influencers, edited images, and sponsored "wellness" content disguised as health advice. In the final segment, Jed chats with author Bate Ilondior, who created the picture book "Joshua's Days of the Week" to support her son's receptive and expressive speech delay. Her personalized, kid-centered stories highlight the powerful link between reading with your kids, language growth, and confidence.

In this episode, Wesley Hartman, co‑author of the Journal of Accountancy's Technology Q&A column, discusses how AI is reshaping work for accounting firms. He explains the difference between generative and agentic AI and why both matter for firm workflows. Hartman also outlines the most pressing AI risks for CPAs, including hallucinations and emerging deepfake‑driven scams, which he wrote about in the February Tech Q&A. He closes the conversation with practical guidance for adopting AI tools methodically while avoiding common pitfalls. Also, here are a few Technology Q&A columns related to the discussion: "How CPAs Can Combat the Rising Threat of Deepfake Fraud," May 1, 2025 "AI-Powered Hacking in Accounting: 'No One Is Safe'," Oct. 1, 2025 "Creating an AI Agent in ChatGPT," Nov. 1, 2025 What you'll learn from this episode: The ways Hartman uses AI in his own work. The difference between agentic and generative AI. Why "confidently wrong" AI responses can present risks for firms. How inaction or "wait‑and‑see" thinking can create its own form of AI risk.

In this insightful conversation, Cynthia and Cory Hartman of New Generations explore how Disciple‑Making Movement terminology has developed, evolved, and continues to shift as God is at work around the world. Listeners will gain a clearer understanding of commonly used movement terms, their historical context, and why language matters for those engaged in disciple‑making today.

Eddie Hartman is a tech visionary, scale architect, and entrepreneur renowned for co-founding LegalZoom, a company that revolutionized legal access for millions by bringing legal empowerment to the masses. With a track record of launching new ventures and mentoring the next generation of founders, Eddie is known for his relentless innovation and practical wisdom. As an author, he co-wrote "Monetizing Innovation" and "Scaling Innovation," essential reads for anyone serious about building sustainable businesses. His life's mission is to help others not just survive the challenges of entrepreneurship but truly thrive. Takeaways: Embrace Both Success and Failure: Eddie believes that entrepreneurs should discuss their failures as openly as their successes, highlighting the importance of resilience and learning from setbacks. Value and Pricing Are Everything: A common blind spot for founders is not testing whether customers will actually pay for their product, and undervaluing their services is a typical misstep. Charging based on real value—and being willing to ask for more—is crucial for growth. Recurring Revenue and Relationships Win: Transitioning from one-time transactions to ongoing relationships, such as subscriptions, can transform any business—even the most traditional industries—by focusing on long-term customer value and retention. Sound Bytes: "You do not have to face the odds which are daunting that most people face as entrepreneurs today. There are a few things you can do to radically improve your chances of success." "If you only perfect the recipe and get it out there, but people aren't willing to pay what you need, then you're not in possession of a business idea—you've got a great hobby." "Every person who leaves you as a customer at one point said yes. Your job is to figure out what changed between yes and cancellation." Connect & Discover Eddie: LinkedIn: @eddie-hartman X: @EddieRHartman Book: Scaling Innovation: How Smart Companies Architect Profitable Growth

Eddie Hartman is a tech visionary, scale architect, and entrepreneur renowned for co-founding LegalZoom, a company that revolutionized legal access for millions by bringing legal empowerment to the masses. With a track record of launching new ventures and mentoring the next generation of founders, Eddie is known for his relentless innovation and practical wisdom. As an author, he co-wrote "Monetizing Innovation" and "Scaling Innovation," essential reads for anyone serious about building sustainable businesses. His life's mission is to help others not just survive the challenges of entrepreneurship but truly thrive.Takeaways:Embrace Both Success and Failure: Eddie believes that entrepreneurs should discuss their failures as openly as their successes, highlighting the importance of resilience and learning from setbacks.Value and Pricing Are Everything: A common blind spot for founders is not testing whether customers will actually pay for their product, and undervaluing their services is a typical misstep. Charging based on real value—and being willing to ask for more—is crucial for growth.Recurring Revenue and Relationships Win: Transitioning from one-time transactions to ongoing relationships, such as subscriptions, can transform any business—even the most traditional industries—by focusing on long-term customer value and retention.Sound Bytes:"You do not have to face the odds which are daunting that most people face as entrepreneurs today. There are a few things you can do to radically improve your chances of success.""If you only perfect the recipe and get it out there, but people aren't willing to pay what you need, then you're not in possession of a business idea—you've got a great hobby.""Every person who leaves you as a customer at one point said yes. Your job is to figure out what changed between yes and cancellation."Connect & Discover Eddie:LinkedIn: ⁠@eddie-hartman⁠X: ⁠@EddieRHartman⁠Book: ⁠Scaling Innovation: How Smart Companies Architect Profitable Growth⁠

Two clinicians from different worlds, one vision for the future of rehab. At Graham Sessions, Jimmy sits down with Ali Hartman, DPT and CrossFit enthusiast, and Bethany Ayer, OT and AI strategist, for a wide-ranging conversation about burnout, purpose, and rebuilding the systems we work in.TAKEAWAYS INCLUDE:Why prevention and performance still don't get the spotlight in PTWhat AI is actually doing in healthcare (not the hype)“Conversion factor” of effort vs reward in today's clinicWhy doing well and doing good shouldn't be either/orBorrowing solutions from other professions (yes, even engineers!)???? Featured Guests:???? Ali Hartman, DPTFocus: Prevention, industrial wellness, CrossFit, performance???? Bethany Ayer, OTR/L, MBAClinical Sales LeadBackground in EMR strategy, AI, OT clinical practice